Preliminary Studies with L-Asparaginase Bound to Implantable Bovine Collagen Heterografts: A Potential Long-Term, Sustained Dosage, Antitumor Enzyme Therapy System
Abstract:In this study, L-Asparaginase has been bound to collagen heterografts derived from carotid bovine arteries. The immobilization procedure utilizes both non-covalent and covalent interactions to fix the enzyme. Binding of the enzyme to the graft material was shown to the pH dependent, with optimum binding occurring at pH 6.0 and pH 8.5. Amidohydrolysis by the bound enzyme exhibited zero-order kinetic behavior at substrate saturating conditions. Total apparent asparaginase activity expressed by the grafts as a fu… Show more
“…The modification or immobilization of the enzyme not only reduced its immunity and toxicity to humans but also greatly improved its resistance to proteolysis in comparison with native ASNase. Some attempts have been made to prepare insoluble, matrix‐supports for ASNase immobilization, such as collagen,5 CM‐cellulose,6 polyacrylamide,7 poly (2‐hydroxyethyl methacrylate) gels,8, 9 and PEG–BSA hydrogels 10. This type of derivative may be appropriate for extracorporeal devices in the clinical treatment of ALL.…”
“…The modification or immobilization of the enzyme not only reduced its immunity and toxicity to humans but also greatly improved its resistance to proteolysis in comparison with native ASNase. Some attempts have been made to prepare insoluble, matrix‐supports for ASNase immobilization, such as collagen,5 CM‐cellulose,6 polyacrylamide,7 poly (2‐hydroxyethyl methacrylate) gels,8, 9 and PEG–BSA hydrogels 10. This type of derivative may be appropriate for extracorporeal devices in the clinical treatment of ALL.…”
“…One of the methods for L‐ASNase immobilisation is physical adsorption on the surface of carriers. In this paper, insoluble matrix supports have been used for enzyme immobilisation such as carboxymethyl cellulose [7], collagen [8], poly(2‐hydroxyethyl methacrylate) gels, polyacrylamide [9, 10], and polyethylene glycol and bovine serum albumin hydrogels [11]. Another way for enzyme immobilisation is physical trapping the enzyme in liposomes [12].…”
Acute lymphoblastic leukemia (ALL) is the white blood cell cancer in children. L-asparaginase (L-ASNase) is one of the first drugs used in ALL treatment. Anti-tumor activity of L-ASNase is not specific and indicates limited stability in different biological environments, in addition to its quick clearance from blood. The purpose of the present study was to achieve a new L-ASNase polymer bioconjugate to improve pharmacokinetic, increase half-life and stability of the enzyme. The conjugations were achieved by the cross-linking agent of 1-ethyl-3-(3- dimethylaminopropyl) carbodiimide (EDC) which activates the carboxylic acid groups of polymeric nanoparticles to create amide bond. EDC conjugated the L-ASNase to two biodegradable polymers including; Ecoflex and poly (styrene-co-maleic acid) (PSMA) nanoparticles. To achieve optimal L-ASNase nanoparticles the amounts of each polymer and the crosslinker were optimized and the nanoparticles were characterized according to their particle size, zeta potential and percent of conjugation of the enzyme. The results showed that conjugated enzyme had more stability against pH changes and proteolysis. It had lower Km value (indicating more affinity to the substrate) and greater half-life in plasma and phosphate buffered saline, in comparison to native enzyme. Generally, the conjugated enzyme to PSMA nanoparticles showed greater results than Ecoflex nanoparticles.
“…It has been reported that the immobilized enzyme not only reduces toxicity, but also greatly improved resistance to proteolysis compared to native L-asparaginase (Zhang et al, 2004;Ghosha et al, 2011). Attempts were made for the preparation of insoluble matrix supports such as collagen (Jefferies et al, 1977), carboxy methyl cellulose (Hasselberger et al, 1970), polyacrylamide and poly (2-hydroxyethyl methacrylate) gels (O'Driscoll et al, 1975) derivatives bioconjucated with L-asparaginase for use in cancer therapy. That said, enzyme immobilization has attracted great interest by chemists and biochemists for its wide application in academic research and industrial processes (Mahmoud and Helmy, 2009;Shafei et al, 2015).…”
A b s t r a c tGamma irradiation is used on Penicillium cyclopium in order to obtain mutant cells of high L-asparaginase productivity. Using gamma irradiation dose of 4 KGy, P. cyclopium cells yielded L-asparaginase with extracellular enzyme activity of 210.8 ± 3 U/ml, and specific activity of 752.5 ± 1.5 U/mg protein, which are 1.75 and 1.53 times, respectively, the activity of the wild strain. The enzyme was partially purified by 40-60% acetone precipitation. L-asparaginase was immobilized onto Amberlite IR-120 by ionic binding. Both free and immobilized enzymes exhibited maximum activity at pH 8 and 40°C. The immobilization process improved the enzyme thermal stability significantly. The immobilized enzyme remained 100% active at temperatures up to 60°C, while the free asparaginase was less tolerant to high temperatures. The immobilized enzyme was more stable at pH 9.0 for 50 min, retaining 70% of its relative activity. The maximum reaction rate (V max ) and Michaelis-Menten constant (K m ) of the free form were significantly changed after immobilization. The K m value for immobilized L-asparaginase was about 1.3 times higher than that of free enzyme. The ions K + , Ba 2+ and Na + showed stimulatory effect on enzyme activity with percentages of 110%, 109% and 106% respectively. K e y w o r d s: Penicillium cyclopium, Amberlite IR-120, gamma irradiation, ionic binding immobilization, L-asparaginase
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.